Cargando…

Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes

The Lesotho guidelines for the management of drug-resistant tuberculosis (TB) recommend initiation of patients diagnosed with rifampicin resistant (RR)-TB on a standardized drug resistant regimen while awaiting confirmation of rifampicin resistant TB (RR-TB) and complete drug susceptibility test res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katende, Bulemba, Esterhuizen, Tonya M., Dippenaar, Anzaan, Warren, Robin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002499/ https://www.ncbi.nlm.nih.gov/pubmed/32024860 http://dx.doi.org/10.1038/s41598-020-58690-4

Ejemplares similares

Linkage to care and treatment outcomes for patients diagnosed with drug-susceptible tuberculosis using Xpert MTB/RIF assay in Thaba-Tseka district in Lesotho
por: Mabote, Nteseng, et al.
Publicado: (2022)

Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
por: Feliciano, Cinara Silva, et al.
Publicado: (2019)

Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis: insights from a qualitative study
por: Tu, Pham Hien Trang, et al.
Publicado: (2022)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

Incidental radiological findings during clinical tuberculosis screening in Lesotho and South Africa: a case series
por: Glaser, Naomi, et al.
Publicado: (2023)

Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study
por: Goig, Galo A, et al.
Publicado: (2023)

Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study
por: Cox, Helen, et al.
Publicado: (2022)

Fighting an old disease with next-generation sequencing
por: Dippenaar, Anzaan, et al.
Publicado: (2015)

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
por: Cox, Helen, et al.
Publicado: (2021)

Facilitators and barriers to COVID-19 testing in community and clinical settings: Lessons learned from Lesotho and Zambia
por: Simwinga, Musonda, et al.
Publicado: (2023)

Outcomes of Multidrug-Resistant Tuberculosis Treatment with Early Initiation of Antiretroviral Therapy for HIV Co-Infected Patients in Lesotho
por: Satti, Hind, et al.
Publicado: (2012)

Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008)

The Detection of Mutations and Genotyping of Drug-Resistant Mycobacterium tuberculosis Strains Isolated from Patients in the Rural Eastern Cape Province
por: Faye, Lindiwe M., et al.
Publicado: (2023)

Spatial Distribution of Drug-Resistant Mycobacterium tuberculosis Infections in Rural Eastern Cape Province of South Africa
por: Faye, Lindiwe M., et al.
Publicado: (2023)

Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho
por: Labhardt, Niklaus D., et al.
Publicado: (2023)

COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho
por: Andom, Afom T., et al.
Publicado: (2023)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho
por: Katende, Bulemba, et al.
Publicado: (2023)

Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods
por: Mwanza, Winnie, et al.
Publicado: (2018)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Creating access to SARS-CoV-2 screening and testing through community-based COVID-19 case-finding, observations from cross-sectional studies in Lesotho and Zambia
por: Klinkenberg, Eveline, et al.
Publicado: (2023)

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2023)

Nanopore Sequencing for Mycobacterium tuberculosis: a Critical Review of the Literature, New Developments, and Future Opportunities
por: Dippenaar, Anzaan, et al.
Publicado: (2022)

Compliance of St Joseph's Hospital Roma, Lesotho with the National Tuberculosis Programme of Lesotho, 2007 and 2008
por: Samuel, Oladoyinbo O., et al.
Publicado: (2014)

Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
por: Oostvogels, Selien, et al.
Publicado: (2022)

Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis
por: Bouton, Tara C., et al.
Publicado: (2019)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes
por: Decroo, Tom, et al.
Publicado: (2020)

Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015
por: Matambo, Ronnie, et al.
Publicado: (2020)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
por: Schmaltz, Carolina Arana Stanis, et al.
Publicado: (2019)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Detection of minor variants in Mycobacterium tuberculosis whole genome sequencing data
por: Goossens, Sander N, et al.
Publicado: (2021)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Evaluating determinants of treatment outcomes among tuberculosis patients in the mining district of Butha Buthe, Lesotho
por: Ngah, Veranyuy D., et al.
Publicado: (2022)

Improving early childhood care and development, HIV-testing, treatment and support, and nutrition in Mokhotlong, Lesotho: study protocol for a cluster randomized controlled trial
por: Tomlinson, Mark, et al.
Publicado: (2016)

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
por: Sayfutdinov, Zayniddin, et al.
Publicado: (2021)

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
por: Gopie, F.A., et al.
Publicado: (2021)

Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household
por: Apolisi, Ivy, et al.
Publicado: (2023)

Utilisation of village health workers’ services for tuberculosis screening in Lesotho
por: Thetsane, Regina M., et al.
Publicado: (2022)

The Impact of COVID-19 on Tuberculosis Program Performance in the Kingdom of Lesotho
por: Andom, Afom T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2kcv85h5c59d9fo7svpcgab7oi